Abstract
Dentsply Sirona will report fiscal second-quarter 2026 results on August 06, 2026, Post Market; this preview distills the latest company guidance, prior-quarter performance, and current sell-side expectations into a concise outlook on revenue, profits, margins, and EPS alongside key business drivers.Market Forecast
Consensus for the current quarter points to revenue of 889.07 million US dollars, an estimated year-over-year decline of 4.74%, with EBIT forecast at 114.05 million US dollars (down 21.59% YoY) and adjusted EPS expected at 0.35 (down 30.56% YoY). Margin expectations embed pressure versus last year; the company’s internal projections imply weaker operating leverage with estimated declines in both EBIT and EPS year over year, while revenue trends remain slightly negative.The main business profile remains balanced across core dental consumables, connected/digital technologies, and orthodontics/implants, with management focus on mix improvement and disciplined cost control. Within the portfolio, connected technology solutions are positioned as a medium-term growth engine given continued adoption of digital workflows and chairside systems.
Last Quarter Review
In the previous quarter, Dentsply Sirona reported revenue of 880.00 million US dollars (up 0.11% YoY), a gross profit margin of 48.52%, GAAP net profit attributable to shareholders of -10.00 million US dollars with a net profit margin of -1.14%, and adjusted EPS of 0.27 (down 37.21% YoY). Operating performance reflected soft demand and unfavorable mix, while cost actions partly mitigated pressure; revenue contributions were led by Basic Dental Solutions at 350.00 million US dollars, Connected Technology Solutions at 246.00 million US dollars, Orthodontic and Implant Solutions at 199.00 million US dollars, and Wellspect Healthcare at 85.00 million US dollars.Current Quarter Outlook
Main business: Core dental consumables and treatment categories
The company’s core dental solutions anchor overall revenue and cash generation and typically offer resilient demand through routine procedures. For this quarter, the slight revenue decline implied by consensus suggests procedure volumes are stable to soft, while price/mix remains neutral to slightly negative. With gross margin in the prior quarter at 48.52%, sustaining margin near the high-40s will likely depend on consumables mix and procurement efficiencies; any elevated promotional spend to protect share could weigh on operating margin. Watch for commentary on restocking patterns in North America and Europe and whether the cadence of distributor inventory normalization is largely complete, as this has been a swing factor for sell-in versus sell-through.Most promising business: Connected/digital technologies
Digital dentistry, including connected technology solutions (such as imaging, CAD/CAM, and chairside systems), remains the company’s structural growth lane in the medium term. Although the quarter’s topline is projected down year over year, digital workflows continue to penetrate clinics, and deferred capital purchases may begin to normalize as macro conditions stabilize. Execution on software attachment, service contracts, and installed-base utilization can support margin quality even if new system placements are uneven. If management highlights higher attach rates for software and accessories or improved utilization metrics, the segment’s revenue durability and margin accretion could offset softer hardware cycles. The company’s ability to bundle solutions and simplify digital adoption for general practitioners remains a lever for incremental growth.Stock-price swing factors: Margins, cost actions, and capital equipment demand
Investors will focus on whether operating margin stabilizes despite the anticipated revenue dip, especially given the guided declines in EBIT and EPS year over year. The spread between gross margin performance and opex discipline is pivotal; sustained cost controls versus reinvestment for growth will determine near-term EPS trajectory. Capital equipment demand is another swing factor: a rebound in imaging and chairside systems could deliver upside to revenue and mix, while further caution on big-ticket purchases would reinforce the consensus bias for margin pressure. FX volatility, regional recovery sequencing, and any updates on portfolio streamlining or capital allocation will also influence sentiment into and after the print.Analyst Opinions
Across recent previews, the balance of opinions skews cautious, with most analysts emphasizing near-term margin pressure and capital equipment demand softness against a constructive medium-term view on digital adoption and portfolio quality. Institutions expect revenue contraction of roughly 4–5% year over year and model EBIT and EPS declines consistent with consensus, citing muted procedure growth and channel normalization as headwinds. Several sell-side notes stress that visibility on a broader equipment recovery remains limited, while upside could come from improving consumables momentum and early signs of stabilization in ordering patterns.Cautious views from well-followed analysts highlight the risk that operating leverage remains negative this quarter given slower revenue, even if cost initiatives continue to progress. Their frameworks typically focus on sensitivity to high-margin categories and the timing of capital purchase cycles; as a result, consensus brackets near the lower end of prior ranges for EPS. Analysts also note that while the digital business offers attractive long-term economics, quarter-to-quarter volatility in placements and FX could cap near-term upside. The prevailing view is that execution on cost structure and clarity around distributor inventory normalization will be prerequisites for a more constructive stance later this year.
Comments